![]() |
市场调查报告书
商品编码
1822479
2032 年农业生物技术市场预测:按产品类型、性状类型、作物类型、技术、分销管道、最终用户和地区进行的全球分析Agricultural Biotechnology Market Forecasts to 2032 - Global Analysis By Product Type, Trait Type, Crop Type, Technology, Distribution Channel, End User and By Geography |
根据 Stratistics MRC 的数据,全球农业生物技术市场预计到 2025 年将达到 1,373 亿美元,到 2032 年将达到 2,478 亿美元,预测期内的复合年增长率为 8.8%。
农业生物技术涉及应用包括基因工程和分子生物学在内的科学技术来改良作物、牲畜和耕作方法。这使得开发具有抗虫、耐旱和产量等特性的基因改造生物 (GMO) 成为可能。该技术透过减少化学投入、提高粮食安全和促进环境保护来支持永续农业。农业生物技术在应对粮食生产、气候变迁和资源效率等全球挑战方面发挥关键作用。
根据《印度农业科学杂誌》报道,基改作物在印度的引进对农业生产力产生了重大影响。例如,Bt棉花是印度唯一核准商业性批准的基因改造作物,到2022年,其种植面积已超过1,140万公顷,占全国棉花总种植面积的90%以上。该杂誌发表的一项研究报告称,Bt棉花使产量提高了24%,农药使用量减少了50%,有助于提高农场收入并改善环境。
全球人口成长与粮食安全问题
农业生物技术已成为关键解决方案,它能够开发出抗病虫害和环境胁迫的基因改造作物。这些创新对于提高粮食供应和营养品质至关重要,尤其是在面临气候变迁的地区。 CRISPR 和RNA干扰等技术正被用于改造具有优良性状的作物,帮助解决营养不良和粮食不安全问题。为了确保长期粮食安全和永续的农业实践,各国政府和国际组织正在加强对生物技术研究的支持。
监管障碍和冗长的核准流程
基因改造作物(GMO)和生物工程产品的核准流程通常涉及广泛的安全评估、环境影响评估和公众咨询。虽然这些程式对于保护消费者至关重要,但对于开发者来说却耗时费力。各国法律规范的差异进一步加剧了全球市场准入的复杂性,并限制了创新的步伐。此外,公众的质疑和围绕作物的伦理争议加剧了政策惰性,阻碍了其更广泛的应用。
农业生物技术与数位技术的结合
遥感探测和基因组数据分析等人工智慧生物资讯学工具正在提高性状选择的准确性并加快育种週期。这种整合使农民能够监测作物健康状况、预测产量并更有效地利用投入。数位平台也促进了即时决策并提高了供应链透明度。随着智慧农业的普及,生物技术公司正在投资数位基础设施,以提供客製化解决方案,从而提高生产力和永续性。
对小农户的社会经济影响
生物技术种子、许可费和专有技术的高成本可能会限制资源受限的农民取得这些技术。此外,依赖取得专利的性状可能会削弱种子主权,增加财务脆弱性。向生物技术密集型农业的转变也可能扰乱传统的耕作方式,导致农村社区的社会经济地位下降。解决这些问题需要全面的政策、能力建设措施以及公平获取生物技术创新的机会。
新冠疫情对农业生物技术市场产生了双重影响,既扰乱了供应链,也加速了创新。停工和劳动力短缺影响了田间试验、种子生产和分销网络,导致产品上市延迟。然而,这场危机也凸显了建立韧性粮食作物的必要性,并刺激了对生物技术解决方案的投资增加。各国政府已将气候适应性和抗病作物的研究列为优先事项,以减轻未来的干扰。
农作物保护产品市场预计将成为预测期内最大的市场
农作物保护产品领域预计将在预测期内占据最大的市场份额,因为它在保护产量免受病虫害侵害方面发挥着至关重要的作用。基于生物技术的杀虫剂、除草剂和杀菌剂因其针对性强且环境安全,越来越受到化学替代品的青睐。微生物生物农药和基于RNAi的害虫防治创新技术正日益受到欢迎,因为它们为病虫害综合治理提供了永续的解决方案。
预测期内,抗虫细分市场预计将以最高复合年增长率成长
预计抗虫作物领域将在预测期内实现最高成长率,这主要得益于减少作物损失和最大程度减少农药使用的需求。基因工程技术正被用于培育表达杀虫蛋白的作物,从而提供对主要害虫的内在保护。这些特性不仅提高了产量稳定性,也降低了农民的投入成本。 CRISPR 和基因堆迭技术的发展使得多重抗性品种的开发成为可能,扩大了抗虫生物基作物在不同地区的覆盖范围。
预计北美将在预测期内占据最大的市场份额,这得益于其强大的科研基础设施、良好的法规环境以及基因改造作物的广泛应用。该地区拥有多家大型生物技术公司和学术机构,正在推动基因工程和合成生物学领域的创新。政府对生物技术研发和精密农业计画的大力支持,进一步推动了市场成长。
受粮食需求成长、气候挑战和农业投资扩张的推动,亚太地区预计将在预测期内呈现最高的复合年增长率。中国、印度和印尼等国家正积极拥抱生物技术创新,以提高作物的抗逆性并减少对进口的依赖。政府推动的基因改造作物试验、数位农业和生物技术教育计画正在加速该地区的生物技术应用。亚太地区多样化的农业气候区也为客製化生物技术应用提供了机会,使其成为未来农业生物技术发展的热点。
According to Stratistics MRC, the Global Agricultural Biotechnology Market is accounted for $137.3 billion in 2025 and is expected to reach $247.8 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Agricultural biotechnology involves the application of scientific techniques, including genetic engineering and molecular biology, to improve crops, livestock, and farming practices. It enables the development of genetically modified organisms (GMOs) with enhanced traits such as pest resistance, drought tolerance, and increased yield. This technology supports sustainable agriculture by reducing chemical inputs, improving food security, and promoting environmental conservation. Agricultural biotechnology plays a vital role in addressing global challenges related to food production, climate change, and resource efficiency.
According to the Indian Journal of Agricultural Sciences, the adoption of genetically modified (GM) crops in India has significantly impacted agricultural productivity. For instance, Bt cotton India's only commercially approved GM crop was cultivated on over 11.4 million hectares by 2022, accounting for over 90% of the country's total cotton area. Studies published in the journal report that Bt cotton has led to a 24% increase in yield and a 50% reduction in pesticide use, contributing to improved farmer income and environmental outcomes.
Growing global population and food security concerns
Agricultural biotechnology is emerging as a pivotal solution, enabling the development of genetically modified crops that offer improved resistance to pests, diseases, and environmental stressors. These innovations are crucial for enhancing food availability and nutritional quality, especially in regions facing climate volatility. Technologies such as CRISPR and RNA interference are being leveraged to engineer crops with superior traits, helping address malnutrition and food scarcity. Governments and international bodies are increasingly supporting biotech research to ensure long-term food security and sustainable farming practices
Regulatory hurdles and lengthy approval processes
Approval processes for genetically modified organisms (GMOs) and bioengineered products often involve extensive safety evaluations, environmental impact assessments, and public consultations. These procedures, while essential for consumer protection, can be time-consuming and costly for developers. Variability in regulatory frameworks across countries further complicates global market entry, limiting the pace of innovation. Moreover, public skepticism and ethical debates surrounding GM crops contribute to policy inertia, hindering broader adoption
Integration of agricultural biotechnology with digital technologies
Tools such as AI-driven bioinformatics remote sensing and genomic data analytics are enhancing the accuracy of trait selection and accelerating breeding cycles. This integration allows farmers to monitor crop health, predict yield outcomes, and apply inputs more efficiently. Digital platforms are also facilitating real-time decision-making and improving supply chain transparency. As smart farming gains traction, biotech firms are investing in digital infrastructure to deliver tailored solutions that boost productivity and sustainability
Socio-economic impacts on small farmers
High costs associated with biotech seeds, licensing fees, and proprietary technologies can limit accessibility for resource-constrained farmers. Additionally, dependence on patented traits may reduce seed sovereignty and increase financial vulnerability. The shift toward biotech-intensive farming could also disrupt traditional agricultural practices, leading to socio-economic displacement in rural communities. Addressing these concerns requires inclusive policies, capacity-building initiatives, and equitable access to biotech innovations
The COVID-19 pandemic had a dual impact on the agricultural biotechnology market, disrupting supply chains while accelerating innovation. Lockdowns and labor shortages affected field trials, seed production, and distribution networks, causing delays in product launches. However, the crisis also underscored the need for resilient food systems, prompting increased investment in biotech solutions. Governments prioritized research on climate-resilient and disease-resistant crops to mitigate future disruptions.
The crop protection products segment is expected to be the largest during the forecast period
The crop protection products segment is expected to account for the largest market share during the forecast period due to their critical role in safeguarding yields against pests and diseases. Biotech-based pesticides, herbicides, and fungicides are increasingly preferred over chemical alternatives for their targeted action and environmental safety. Innovations in microbial biopesticides and RNAi-based pest control are gaining traction, offering sustainable solutions for integrated pest management.
The insect-resistant segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the insect-resistant segment is predicted to witness the highest growth rate driven by the need to reduce crop losses and minimize pesticide usage. Genetic engineering techniques are being employed to develop crops that express insecticidal proteins, offering built-in protection against major pests. These traits not only enhance yield stability but also lower input costs for farmers. Advances in CRISPR and gene stacking are enabling the development of multi-resistant varieties, expanding the scope of insect-resistant biotech crops across diverse geographies.
During the forecast period, the North America region is expected to hold the largest market share owing to its robust research infrastructure, favorable regulatory environment, and widespread adoption of GM crops. The region is home to several biotech giants and academic institutions driving innovation in genetic engineering and synthetic biology. Strong government support for biotech R&D and precision agriculture initiatives further bolsters market growth.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGRfueled by rising food demand, climate challenges, and expanding agricultural investments. Countries like China, India, and Indonesia are embracing biotech innovations to enhance crop resilience and reduce dependency on imports. Government programs promoting GM crop trials, digital farming, and biotech education are accelerating regional adoption. The region's diverse agro-climatic zones also present opportunities for tailored biotech applications, making Asia Pacific a hotspot for future growth in agricultural biotechnology.
Key players in the market
Some of the key players in Agricultural Biotechnology Market include Bayer AG, Corteva Agriscience, Syngenta AG, BASF SE, FMC Corporation, Novozymes A/S, Valent BioSciences LLC, Certis USA LLC, Evogene Ltd., KWS SAAT SE, Indigo Agriculture, Inc., Bioceres Crop Solutions Corp., Ginkgo Bioworks Holdings Inc., UPL (Natural Plant Protection - NPP), RovensaNext, BioFirst and De Sangosse.
In September 2025, BASF partnered with Arkema and AkzoNobel to reduce carbon footprint of Interpon powder coatings by up to 40%. It supplies bio-attributed neopentyl glycol (NPG ZeroPCF), enabling sustainable building materials.
In August 2025, Corteva and Insecticides India launched SPARCLE, a broad-spectrum insecticide targeting brown plant hopper in rice. The product combines Corteva's advanced chemistry with IIL's distribution network to improve crop yield and profitability.
In June 2025, Novonesis acquired DSM-Firmenich's share of the Feed Enzyme Alliance for €1.5 billion. This move strengthens Novonesis' position in animal biosolutions and expands its distribution.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.